Functional genetics reveals the contribution of delta opioid receptor to type 2 diabetes and beta-cell function
Open Access
- 5 August 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-12
Abstract
Functional genetics has identified drug targets for metabolic disorders. Opioid use impacts metabolic homeostasis, although mechanisms remain elusive. Here, we explore the OPRD1 gene (encoding delta opioid receptor, DOP) to understand its impact on type 2 diabetes. Large-scale sequencing of OPRD1 and in vitro analysis reveal that loss-of-function variants are associated with higher adiposity and lower hyperglycemia risk, whereas gain-of-function variants are associated with lower adiposity and higher type 2 diabetes risk. These findings align with studies of opium addicts. OPRD1 is expressed in human islets and beta cells, with decreased expression under type 2 diabetes conditions. DOP inhibition by an antagonist enhances insulin secretion from human beta cells and islets. RNA-sequencing identifies pathways regulated by DOP antagonism, including nerve growth factor, circadian clock, and nuclear receptor pathways. Our study highlights DOP as a key player between opioids and metabolic homeostasis, suggesting its potential as a therapeutic target for type 2 diabetes.Keywords
This publication has 60 references indexed in Scilit:
- TIGER: The gene expression regulatory variation landscape of human pancreatic isletsCell Reports, 2021
- Persistent or Transient Human β Cell Dysfunction Induced by Metabolic Stress: Specific Signatures and Shared Gene Expression with Type 2 DiabetesCell Reports, 2020
- Purification of pancreatic endocrine subsets reveals increased iron metabolism in beta cellsMolecular Metabolism, 2020
- A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety dataJournal of Diabetes and its Complications, 2017
- Expression and functional assessment of candidate type 2 diabetes susceptibility genes identify four new genes contributing to human insulin secretionMolecular Metabolism, 2017
- Rare and Common Genetic Events in Type 2 Diabetes: What Should Biologists Know?Cell Metabolism, 2015
- A Unified Mixed‐Effects Model for Rare‐Variant Association in Sequencing StudiesGenetic Epidemiology, 2013
- Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCRDrug and Alcohol Dependence, 2012
- Further Evidence of Association of OPRD1 & HTR1D Polymorphisms with Susceptibility to Anorexia NervosaBiological Psychiatry, 2007
- Inhibitory effect of enkephalin on insulin secretion in healthy subjects and in non insulin-dependent diabetic subjectsMetabolism, 1987